cidofovir anhydrous has been researched along with leflunomide in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 11 (64.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Farasati, NA; Randhawa, P; Shapiro, R; Vats, A | 1 |
| Hariharan, S | 1 |
| Chandraker, A; Josephson, MA; Randhawa, PS; Williams, JW | 1 |
| Abdelhalim, A; Almyroudis, NG; Battiwalla, M; Becker, J; Elefante, A; McCarthy, A; McCarthy, PL; Paplham, P; Segal, BH; Smith, P | 1 |
| Busch, M; Gerth, J; Ott, U; Steiner, T; Wolf, G | 1 |
| Epker, JL; van Biezen, P; van Daele, PL; van Gelder, T; van Saase, JL; Vossen, A | 1 |
| Egli, A; Helmersen, DS; Hirsch, HH; Johnson, A; Taub, K | 1 |
| Abdulnour, HA; Araya, CE; Dharnidharka, VR | 1 |
| Andrei, G; Krecmerová, M; Lebeau, I; Snoeck, R; Topalis, D | 1 |
| Basdemir, G; Bayirli Turan, D; Dheir, H; Gurkan, A; Kacar, S; Sahin, S; Turunc, V; Uyar, M | 1 |
| Carmichael, A; Goldsmith, PM; Husain, MM; Middleton, SJ; Zhang, H | 1 |
| Akbaş, SH; Akkaya, B; Akman, S; Cağla Doğan, S; Colak, D; Comak, E; Dinçkan, A; Koyun, M; Mutlu, D; Mutlu, E; Sağlık, I; Süleymanlar, G; Uslu Gökçeoğlu, A | 1 |
| Burger-Calderon, R; Jeffers-Francis, LK; Webster-Cyriaque, J | 1 |
| Agrawal, N; Beltran, D; Echenique, IA; Najafian, N; Ramirez-Ruiz, L | 1 |
5 review(s) available for cidofovir anhydrous and leflunomide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
BK virus nephritis after renal transplantation.
Topics: Antibodies, Viral; Antiviral Agents; BK Virus; Cidofovir; Cytosine; DNA, Viral; Graft Survival; Humans; Immunity, Cellular; Immunosuppressive Agents; Isoxazoles; Kidney; Kidney Transplantation; Leflunomide; Nephritis; Organophosphonates; Polyomavirus Infections; Prevalence; Risk Factors; Treatment Outcome; Tumor Virus Infections; Viremia | 2006 |
Polyomavirus-associated nephropathy: update on antiviral strategies.
Topics: Animals; Antiviral Agents; Cidofovir; Cytosine; Humans; Isoxazoles; Kidney Diseases; Kidney Transplantation; Leflunomide; Organophosphonates; Polyomavirus; Polyomavirus Infections; Quinolones | 2006 |
Progressive multifocal leukoencephalopathy, a review and an extended report of five patients with different immune compromised states.
Topics: Aged; Antiviral Agents; Cidofovir; Cytosine; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Isoxazoles; Leflunomide; Leukoencephalopathy, Progressive Multifocal; Male; Middle Aged; Organophosphonates | 2009 |
The BK virus in renal transplant recipients-review of pathogenesis, diagnosis, and treatment.
Topics: Antiviral Agents; BK Virus; Child; Cidofovir; Cytosine; Humans; Immunosuppressive Agents; Isoxazoles; Kidney Transplantation; Leflunomide; Organophosphonates; Polyomavirus Infections; Reoperation; Treatment Failure | 2011 |
12 other study(ies) available for cidofovir anhydrous and leflunomide
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system.
Topics: Antiviral Agents; BK Virus; Cidofovir; Cytosine; Isoxazoles; Leflunomide; Organophosphonates; Virus Replication | 2005 |
Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation.
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Therapy, Combination; Encephalitis, Viral; Fatal Outcome; Ganciclovir; Hodgkin Disease; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Organophosphonates; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Renal Insufficiency; Secondary Prevention; Treatment Failure; Virus Activation | 2007 |
A single-center experience with BK virus nephropathy.
Topics: Adult; Aged; Antiviral Agents; BK Virus; Cidofovir; Cytosine; Female; Graft Survival; Humans; Immunocompromised Host; Immunosuppressive Agents; Isoxazoles; Kidney Transplantation; Leflunomide; Middle Aged; Nephritis, Interstitial; Organophosphonates; Polyomavirus Infections | 2008 |
Renal failure five years after lung transplantation due to polyomavirus BK-associated nephropathy.
Topics: Adult; Aged; Cidofovir; Cytosine; Female; Humans; Isoxazoles; Kidney Diseases; Leflunomide; Lung Transplantation; Male; Middle Aged; Mycophenolic Acid; Organophosphonates; Polyomavirus Infections; Prednisone; Renal Insufficiency; Tacrolimus; TOR Serine-Threonine Kinases | 2010 |
Activities of different classes of acyclic nucleoside phosphonates against BK virus in primary human renal cells.
Topics: BK Virus; Cell Line; Cell Proliferation; Cidofovir; Cytarabine; Cytosine; Humans; Isoxazoles; Kidney; Leflunomide; Nucleosides; Organophosphonates; Polymerase Chain Reaction; Vidarabine | 2011 |
Intensive polyoma virus nephropathy treatment as a preferable approach for graft surveillance.
Topics: Adult; Antiviral Agents; Cidofovir; Cytosine; Female; Graft Rejection; Graft Survival; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Isoxazoles; Kidney Diseases; Kidney Transplantation; Leflunomide; Male; Middle Aged; Organophosphonates; Polyomavirus Infections; Tacrolimus | 2011 |
Case report: Multidrug-resistant cytomegalovirus in a modified multivisceral transplant recipient.
Topics: Adult; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Multiple, Viral; Female; Foscarnet; Ganciclovir; Humans; Immunosuppressive Agents; Intestine, Small; Isoxazoles; Kidney Transplantation; Leflunomide; Organophosphonates; Pancreas Transplantation; Recurrence; Stomach; Treatment Outcome | 2012 |
[BK virus infections in pediatric kidney transplant recipients].
Topics: Adolescent; Antiviral Agents; BK Virus; Child; Cidofovir; Cytosine; DNA, Viral; Female; Graft Rejection; Humans; Immunosuppressive Agents; Isoxazoles; Kidney Diseases; Kidney Transplantation; Leflunomide; Male; Organophosphonates; Polyomavirus Infections; Tumor Virus Infections; Turkey | 2013 |
Effect of Leflunomide, Cidofovir and Ciprofloxacin on replication of BKPyV in a salivary gland in vitro culture system.
Topics: Animals; Antigens, Viral, Tumor; Antiviral Agents; BK Virus; Cells, Cultured; Cidofovir; Ciprofloxacin; Cytosine; Humans; Isoxazoles; Leflunomide; Organophosphonates; RNA, Messenger; RNA, Viral; Salivary Glands; Time Factors; Viral Load; Virus Replication | 2015 |
Ganciclovir Dosing Strategies and Development of Cytomegalovirus Resistance in a Kidney Transplant Recipient: A Case Report.
Topics: Aged; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Dose-Response Relationship, Drug; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Immunoglobulins; Immunoglobulins, Intravenous; Isoxazoles; Kidney; Kidney Transplantation; Leflunomide; Male; Organophosphonates; Postoperative Complications; Tissue Donors | 2017 |